Рет қаралды 29,471
PCRI's CEO, Alex Scholz, asks medical oncologist, Mark Scholz, MD, about Cyberknife, also known by the generic name stereotactic body radiation therapy or "SBRT." Cyberknife precisely delivers a high dose of beam radiation over a short duration (1 day to 2 weeks) with a side effect profile and cure rates comparable to longer-duration forms of beam radiation like IMRT.
0:06 What is Cyberknife?
2:11 How do the side effects compare to other forms of radiation?
2:50 How does a patient find out if a radiation oncologist and his team are skilled practitioners?
Don’t know your prostate cancer stage? Take the quiz: Visit www.prostatecan...
To learn more about prostate cancer visit www.pcri.org
To download the free Staging Guide visit pcri.org/prost...
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's KZbin channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD